Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Orthofix seeks to understand bone growth technology:

This article was originally published in Clinica

Executive Summary

Orthofix International is funding a trial that will seek to define the molecular and cellular mechanisms of action of its PEMF (pulsed electromagnetic field) technology in stimulating bone growth. The Huntersville, North Carolina firm has given around $2 million to the Orthopaedic Research and Education Foundation as part of a four-year collaboration for the study, which will be conducted at the Cleveland Clinic Foundation, in Ohio. Orthofix plans to expand application of the PEMF platform from bone growth stimulation to other diseases and injuries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066313

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel